News

Protect Your Photoreceptors During Monday’s Solar Eclipse

Protect Your Photoreceptors During Monday’s Solar Eclipse

August 18th, 2017 by FFB Canada

Excitement abounds for the solar eclipse this Monday, August 21, when the moon will briefly pass between the Sun and the Earth. So-called “total eclipses” such as Monday’s offer a rare opportunity to view the full majesty of our most visible celestial neighbours, if only briefly. But if eclipse-gazing is on your schedule, it’s important…

Read More

Are You Living with Diabetes-Related Vision Loss?

Are You Living with Diabetes-Related Vision Loss?

August 17th, 2017 by FFB Canada

Have you developed eye problems as a result of diabetes? The Foundation Fighting Blindness is conducting research into the experiences of patients living with diabetes-related vision loss. If you live in Canada and have both diabetes and vision loss, we want to hear your story. If you’re willing to share your experiences in a short…

Read More

CRISPR: The World’s Preeminent Gene Editing Technology

CRISPR: The World’s Preeminent Gene Editing Technology

August 11th, 2017 by Dr. Chad Andrews

If you’ve been paying attention to developments in gene science over the last several years, you’ve undoubtedly come across the strange-sounding acronym “CRISPR” (pronounced cris-per). It may sound like a breakfast cereal, but it’s revolutionizing the way scientists interact with genetic code. The acronym stands for “Clustered Regularly Interspaced Short Palindromic Repeats,” which for the…

Read More

Five Most Frequently-Asked Vision Science Questions

Five Most Frequently-Asked Vision Science Questions

July 31st, 2017 by FFB Canada

Summer brings sunshine, but also more time for thinking and reading.  At the FFB, we took this opportunity to answer some of your most frequently asked questions about vision research and emerging treatments. We hope you enjoy this summer reading material– keep sending in your questions! 1) When can I expect a cure for my…

Read More

Gene Therapy Improves Vision in Landmark Clinical Trial

Gene Therapy Improves Vision in Landmark Clinical Trial

July 14th, 2017 by Dr. Mary Sunderland

Yesterday, a landmark publication in The Lancet, a prestigious journal, showed that gene therapy can improve vision in people living with a rare blinding eye disease. The study examined the effects of an experimental gene therapy – voretigene neparvovec – to treat an inherited blinding eye disease caused by mutations in the RPE65 gene. RPE65…

Read More

Top 10 Science-y Summer Tips

Top 10 Science-y Summer Tips

June 29th, 2017 by FFB Canada

So far this year, the pace of vision research has been sizzling! To celebrate the arrival of sizzling weather, we asked the Foundation Fighting Blindness (FFB) staff to share their favourite FFB science stories from the archives. Kick back, relax, and enjoy our top 10 list of vision health tips, science stories, and sight-saving science…

Read More

Let’s Talk Gene Therapy Research With Dr. Mary Sunderland & Dr. Chad Andrews (VIDEO)

Let’s Talk Gene Therapy Research With Dr. Mary Sunderland & Dr. Chad Andrews (VIDEO)

June 12th, 2017 by FFB Canada

On the first Tuesday of every month, the Foundation Fighting Blindness sends out our e-newsletter featuring the latest and most exciting research breakthroughs. Soon after each e-newsletter, our very own Director of Research and Education, Dr. Mary Sunderland, takes to our Facebook page to do a live broadcast discussion of the articles featured in the…

Read More

Clinical Trial Updates: Gene Therapy

Clinical Trial Updates: Gene Therapy

June 6th, 2017 by FFB Canada

Many experts agree that gene replacement therapy is a novel approach to treating inherited degenerative retinal diseases, especially when the disease is caused by a single gene defect (or mutation). Gene replacement therapies are sometimes described as “gene addition” or “gene augmentation” therapies because the treatment strategy involves replacing a damaged gene with a new,…

Read More

Will Gene Therapies Win the Race to Restore Sight?

Will Gene Therapies Win the Race to Restore Sight?

June 1st, 2017 by FFB Canada

There is a lot of optimism for the potential to treat inherited eye diseases with gene therapy. Around the world, scientists are exploring ways to fix the genetic errors that lead to gene-based diseases such as retinitis pigmentosa (RP) and Leber’s congenital amaurosis (LCA), editing or creating from scratch the genetic instructions that make sight…

Read More

Experimental Gene Therapy Completes Critical Regulatory Step

Experimental Gene Therapy Completes Critical Regulatory Step

May 26th, 2017 by FFB Canada

For a long time, gene therapy—the idea that genes could be used as a medical treatment—was just that: an idea. Last week, that idea took a leap forward towards becoming a reality when the company, Spark Therapeutics, completed a key application to the Food and Drug Administration (FDA). If successful, this application would make Spark’s…

Read More